TMEM173 protects against pressure overload‐induced cardiac hypertrophy by modulating autophagy

TMEM173 has been reported to participate in endoplasmic reticulum stress, inflammation and immunology, all of which closely involved with cardiac hypertrophy. But its role in autophagy is not fully figured out. In our research, Tmem173 global knockout (KO) mice manifested more deteriorated hypertrophy, fibrosis, inflammatory infiltration and cardiac malfunction compared with wild type C57BL/6 mice after 6 weeks of transverse aortic constriction. And KO mice showed inhibited autophagosome degradation in myocardium observed under transmission electron microscope and in protein level. In in vitro experiments conducted in neonatal rat cardiomyocytes under phenylephrine treatment, the abundance of Tmem173 gene was negatively related to the abundance of LC3‐Ⅱ and the number of red and yellow fluorescent dots, of which reflected the capacity of autophagosome degradation. These results indicated that TMEM173 might be a promoter of autophagic flux and protected against pressure overload‐induced cardiac hypertrophy. It may serve as a potential therapeutic target for cardiac hypertrophy in the future. TMEM173 might be a promoter of autophagic flux and protected against pressure overload‐induced cardiac hypertrophy. It may serve as a potential therapeutic target for cardiac hypertrophy in the future.